The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 05, 2016

Filed:

Feb. 24, 2010
Applicants:

Chelsea M. Byrd, Corvallis, OR (US);

Dongcheng Dai, Corvallis, OR (US);

Robert Jordan, Corvallis, OR (US);

Dennis E. Hruby, Albany, OR (US);

Inventors:

Chelsea M. Byrd, Corvallis, OR (US);

Dongcheng Dai, Corvallis, OR (US);

Robert Jordan, Corvallis, OR (US);

Dennis E. Hruby, Albany, OR (US);

Assignee:

Siga Technologies, Inc., Corvallis, OR (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 495/04 (2006.01); C07D 495/14 (2006.01); A61K 31/44 (2006.01); A61K 31/675 (2006.01); A61K 31/7056 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01); C07D 495/22 (2006.01);
U.S. Cl.
CPC ...
A61K 31/44 (2013.01); A61K 31/675 (2013.01); A61K 31/7056 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); C07D 495/04 (2013.01); C07D 495/14 (2013.01); C07D 495/22 (2013.01);
Abstract

Methods and pharmaceutical compositions for treating viral infections, by administering certain thienopyridine derivative compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus.


Find Patent Forward Citations

Loading…